There were 654 confirmed and 30 probable cases at the end of April. The case count jumped by 71 in the span of one month from March 31, when there were 613 cases reported by the CDC.
Illinois, New Jersey and New York are still reporting the highest number of cases, with New York leading the pack with 334 confirmed and four probable cases.
C. auris, a type of yeast, is often multidrug-resistant and causes bloodstream infections, wound infections and ear infections. People receiving treatment via lines and tubes that go into their body, such as breathing and feeding tubes, seem to be at highest risk for C. auris infection.
C. auris cases have been reported globally, including multiple cases in Australia, Canada, China, Colombia, France, Germany and India.
More articles on healthcare quality:
Nurse practitioners to undergo training for opioid treatment thanks to new law
Joint Commission’s new requirements for suicide prevention take effect July 1
300,000 people flee Congo, risking Ebola’s spread
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
